Taro Appoints New Chief Financial Officer

HAWTHORNE, N.Y., April 10, 2008 (PRIME NEWSWIRE) -- Taro Pharmaceutical
Industries Ltd. ("Taro," the "Company") (Pink Sheets:TAROF) announced today that
Ron Kolker, C.P.A., has been appointed to the position of Senior Vice President,
Chief Financial Officer of the Company and of the Company's U.S. subsidiary,
Taro Pharmaceuticals U.S.A., Inc. ("Taro USA").

Mr. Kolker joined Taro in 1994 and has held a number of roles in finance at the
Company with increasing responsibility. He most recently held the position of
Group Vice President, Corporate Controller in both the Company and Taro USA, and
also served as the Company's Interim Chief Financial Officer for part of 2007.
Mr. Kolker is a Certified Public Accountant and holds an MBA in Finance and
Accounting. Mr. Kolker replaces Thomas E. McClary, who is no longer with the
Company.

Taro is a multinational, science-based pharmaceutical company, dedicated to
meeting the needs of its customers through the discovery, development,
manufacturing and marketing of the highest quality healthcare products. For
further information on Taro Pharmaceutical Industries Ltd., please visit the
Company's website at www.taro.com.

The Taro Pharmaceutical Industries Ltd. logo is available at
http://www.primenewswire.com/newsroom/prs/?pkgid=4733

-0-
CONTACT: Kekst and Company
Roanne Kulakoff
212-521-4837